References
- Stupp R, Hegi ME, Gilbert MR, Chakravarti A. Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 2007; 25:4127 - 4136; PMID: 17827463; http://dx.doi.org/10.1200/JCO.2007.11.8554
- Niyazi M, Siefert A, Schwarz SB, Ganswindt U, Kreth FW, Tonn JC, et al. Therapeutic options for recurrent malignant glioma. Radiother Oncol 2011; 98:1 - 14; PMID: 21159396; http://dx.doi.org/10.1016/j.radonc.2010.11.006
- Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008; 359:492 - 507; PMID: 18669428; http://dx.doi.org/10.1056/NEJMra0708126
- Taphoorn MJ, Sizoo EM, Bottomley A. Review on quality of life issues in patients with primary brain tumors. Oncologist 2010; 15:618 - 626; PMID: 20507891; http://dx.doi.org/10.1634/theoncologist.2009-0291
- Squatrito M, Holland EC. DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance. Cancer Res 2011; 71:5945 - 5949; PMID: 21917735; http://dx.doi.org/10.1158/0008-5472.CAN-11-1245
- Lavin MF. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 2008; 9:759 - 769; PMID: 18813293; http://dx.doi.org/10.1038/nrm2514
- Golding SE, Rosenberg E, Valerie N, Hussaini I, Frigerio M, Cockcroft XF, et al. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion. Mol Cancer Ther 2009; 8:2894 - 2902; PMID: 19808981; http://dx.doi.org/10.1158/1535-7163.MCT-09-0519
- Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 2004; 64:9152 - 9159; PMID: 15604286; http://dx.doi.org/10.1158/0008-5472.CAN-04-2727
- Herzog KH, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 1998; 280:1089 - 1091; PMID: 9582124; http://dx.doi.org/10.1126/science.280.5366.1089
- Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 1999; 13:152 - 157; PMID: 9925639; http://dx.doi.org/10.1101/gad.13.2.152
- Stiff T, O'Driscoll M, Rief N, Iwabuchi K, Löbrich M, Jeggo PA. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 2004; 64:2390 - 2396; PMID: 15059890; http://dx.doi.org/10.1158/0008-5472.CAN-03-3207
- Li X, Lee YK, Jeng JC, Yen Y, Schultz DC, Shih HM, et al. Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression. J Biol Chem 2007; 282:36177 - 36189; PMID: 17942393; http://dx.doi.org/10.1074/jbc.M706912200
- Chalmers AJ, Ruff EM, Martindale C, Lovegrove N, Short SC. Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. Int J Radiat Oncol Biol Phys 2009; 75:1511 - 1519; PMID: 19931733; http://dx.doi.org/10.1016/j.ijrobp.2009.07.1703
- Adams BR, Golding SE, Rao RR, Valerie K. Dynamic dependence on ATR and ATM for double-strand break repair in human embryonic stem cells and neural descendants. PLoS One 2010; 5:10001; PMID: 20368801; http://dx.doi.org/10.1371/journal.pone.0010001
- White JS, Choi S, Bakkenist CJ. Transient ATM kinase inhibition disrupts DNA damage-induced sister chromatid exchange. Sci Signal 2010; 3:44; PMID: 20516478; http://dx.doi.org/10.1126/scisignal.2000758
- Rainey MD, Charlton ME, Stanton RV, Kastan MB. Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation. Cancer Res 2008; 68:7466 - 7474; PMID: 18794134; http://dx.doi.org/10.1158/0008-5472.CAN-08-0763
- Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, et al. Malignant astrocytic glioma: genetics, biology and paths to treatment. Genes Dev 2007; 21:2683 - 2710; PMID: 17974913; http://dx.doi.org/10.1101/gad.1596707
- Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN. Molecularly targeted therapy for malignant glioma. Cancer 2007; 110:13 - 24; PMID: 17520692; http://dx.doi.org/10.1002/cncr.22741
- Weber GL, Parat MO, Binder ZA, Gallia GL, Riggins GJ. Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration and invasion in glioblastoma multiforme cells. Oncotarget 2011; 2:833 - 849; PMID: 22064833
- Hawkins AJ, Golding SE, Khalil A, Valerie K. DNA double-strand break-induced pro-survival signaling. Radiother Oncol 2011; 101:13 - 17; PMID: 21726915; http://dx.doi.org/10.1016/j.radonc.2011.05.074
- Choi S, Gamper AM, White JS, Bakkenist CJ. Inhibition of ATM kinase activity does not phenocopy ATM protein disruption: implications for the clinical utility of ATM kinase inhibitors. Cell Cycle 2010; 9:4052 - 4057; PMID: 20953138; http://dx.doi.org/10.4161/cc.9.20.13471
- Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 2001; 61:2744 - 2750; PMID: 11289157
- Gosink EC, Chong MJ, McKinnon PJ. Ataxia telangiectasia mutated deficiency affects astrocyte growth but not radiosensitivity. Cancer Res 1999; 59:5294 - 5298; PMID: 10537312
- Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444:756 - 760; PMID: 17051156; http://dx.doi.org/10.1038/nature05236
- Khalil A, Morgan RN, Adams BR, Golding SE, Dever SM, Rosenberg E, et al. ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks. Cell Cycle 2011; 10:481 - 491; PMID: 21263216; http://dx.doi.org/10.4161/cc.10.3.14713
- Golding SE, Valerie K. MRE11 and ATM AKTivate pro-survival signaling. Cell Cycle 2011; 10:3227 - 3236; PMID: 21946569; http://dx.doi.org/10.4161/cc.10.19.17048
- Fraser M, Harding SM, Zhao H, Coackley C, Durocher D, Bristow RG. MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks. Cell Cycle 2011; 10:2218 - 2232; PMID: 21623170; http://dx.doi.org/10.4161/cc.10.13.16305